Figure 2.
(a) PFS according to HSCT.(b) PFS between patients receiving first HSCT versus second HSCT in Group 2.
HSCT, hematopoietic stem-cell transplantation; KRd, carfilzomib-lenalidomide-dexamethasone; PFS, progression-free survival.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.